Clara D Christ
Head of Molecular Design, Bayer AG
Dr. Clara Christ is Vice President, Head of Molecular Design at Bayer AG where her team focuses on advancing drug discovery projects with structural insights and digital means. She has worked as a computational chemist at Bayer AG since 2013 focusing on drug design in the therapy area oncology. Besides giving computational chemistry support in all stages of research projects she has been working on improving methods in the areas of de novo design, structure property analysis, and binding affinity prediction. She holds a diploma (2005) and doctorate (2009) degree in chemistry from ETH Zürich. During her doctoral studies with Wilfred van Gunsteren she has developed a method to calculate multiple free energy differences from a single simulation.